Replies

You embarrass yourself...20 year studies do not support "turbo" cancer assertions, nor do experiments adding chemical compositions to existing mRNA vaccines, or earlier cancer screenings that lead to non-symptomatic early stage diagnoses (and treatment).

From the Cancer rates in Australians article:

"But over the last 20 years, there's been a real — it's small in absolute numbers — but it is a real increase in the number of younger adults developing these cancers."

From the Raphael Lataster article:

“Evidence is provided that adding 100 % of N1-methyl-pseudouridine (m1Ψ) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development. Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100 % m1Ψ modification, but rather ones with the lower percentage of m1Ψ modification to avoid immune suppression.”

From the Daily Caller article:

“It's not only thrilling to see the increase in colorectal cancer screening among younger adults, but also how it likely ties into rises in earlier stage diagnosis as noted in the other ACS led paper,” said Jessica Star, MPH, MA, associate scientist, cancer risk factors and screening surveillance research at the American Cancer Society, and lead author of this study.

From the Preprints paper:

This version is not peer-reviewed.